Research team finds new dual benefit mode of action for a drug candidate to fight COVID-19
A research team led by Prof. Stephan Ludwig, a virologist at the Institute of Virology at the University of Münster, has found a new dual attack mode of action while working on the development of a drug candidate against ...
Jan 14, 2022
0
201